HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.

Abstract
The hypotensive effects of N-[8-amino-1(S)-carboxyoctyl] -L-alanyl-L-proline (AB-47, CAS 120008-53-9) were examined in normotensive rats and various hypertensive rat models. The hemodynamic effect of AB-47 was also examined in anesthetized spontaneously hypertensive rats (SHR). In 2-kidney, 1-clip renal hypertensive rats (2K, 1C-RHR) and SHR, the single administration of AB-47 (10 mg/kg, p.o.) induced potent and long-lasting hypotensive effects. The repeated administration of AB-47 (1 to 10 mg/kg, p.o.) to SHR for 29 days produced a dose-dependently and sustained hypotensive effect of 20 to 70 mmHg. AB-47 (10 mg/kg, p.o.) had a weak hypotensive effect in DOCA-salt hypertensive rats but no effects in normotensive and 1-kidney, 1-clip renal hypertensive rats (1K, 1C-RHR). AB-47 (3 mg/kg, p.o.) reduced blood pressure in intact SHR but not in bilateral nephrectomized SHR. The single intravenous injection of AB-47 (10 to 100 micrograms/kg) dose-dependently lowered systemic blood pressure, left ventricular systolic pressure (LVSP) and dp/dtmax without affecting heart rate (HR) and these effects of AB-47 were more potent than those of captopril and enalaprilat. These results suggest that AB-47 is a potent and long-lasting hypotensive agent and may be useful for the therapy of both hypertension and congestive heart failure.
AuthorsM Shirota, M Iijima, T Ushijima, Y Kajiwara, K Kitabatake
JournalArzneimittel-Forschung (Arzneimittelforschung) Vol. 40 Issue 12 Pg. 1303-9 (Dec 1990) ISSN: 0004-4172 [Print] Germany
PMID2095126 (Publication Type: Journal Article)
Chemical References
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Dipeptides
  • N-(8-amino-1-carboxyoctyl)-alanyl-proline
  • Desoxycorticosterone
  • Enalapril
  • Captopril
Topics
  • Administration, Oral
  • Angiotensin-Converting Enzyme Inhibitors (administration & dosage, pharmacology)
  • Animals
  • Antihypertensive Agents
  • Blood Pressure (drug effects)
  • Captopril (pharmacology, therapeutic use)
  • Desoxycorticosterone
  • Dipeptides (administration & dosage, pharmacology)
  • Enalapril (pharmacology, therapeutic use)
  • Hemodynamics (drug effects)
  • Hypertension (chemically induced, drug therapy)
  • Hypertension, Renal (drug therapy, physiopathology)
  • Injections, Intravenous
  • Male
  • Nephrectomy
  • Rats
  • Rats, Inbred SHR
  • Rats, Inbred WKY

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: